Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Philipp Heumann"'
Autor:
Karsten Gülow, Deniz Tümen, Philipp Heumann, Stephan Schmid, Arne Kandulski, Martina Müller, Claudia Kunst
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 11, p 6114 (2024)
Reactive oxygen species (ROS) are central to inter- and intracellular signaling. Their localized and transient effects are due to their short half-life, especially when generated in controlled amounts. Upon T cell receptor (TCR) activation, regulated
Externí odkaz:
https://doaj.org/article/583143dbe9404e2590d294e4a7a2994f
Autor:
Jordi Yang Zhou, Dominik Eder, Florian Weber, Philipp Heumann, Katharina Kronenberg, Jens M. Werner, Edward K. Geissler, Hans J. Schlitt, James A. Hutchinson, Florian Bitterer
Publikováno v:
Frontiers in Transplantation, Vol 2 (2023)
BackgroundThe approval of Atezolizumab / Bevacizumab therapy (Atezo/Bev) in 2020 opened up a promising new treatment option for patients with end-stage hepatocellular carcinoma (HCC). However, liver transplant (LTx) patients with HCC are still denied
Externí odkaz:
https://doaj.org/article/f62aab5a93d84130a02b902ad9f3715e
Autor:
Marlen Michalski, Magdalena Bauer, Franziska Walz, Deniz Tümen, Philipp Heumann, Petra Stöckert, Manuela Gunckel, Claudia Kunst, Arne Kandulski, Stephan Schmid, Martina Müller, Karsten Gülow
Publikováno v:
Biomedicines, Vol 11, Iss 6, p 1666 (2023)
Despite the recent approval of new therapies, the prognosis for patients with hepatocellular carcinoma (HCC) remains poor. There is a clinical need for new highly effective therapeutic options. Here, we present a combined application of BH3-mimetics
Externí odkaz:
https://doaj.org/article/32cdf933719441d7bc376b5845017e2c
Autor:
Deniz Tümen, Philipp Heumann, Karsten Gülow, Cagla-Nur Demirci, Lidia-Sabina Cosma, Martina Müller, Arne Kandulski
Publikováno v:
Biomedicines, Vol 10, Iss 12, p 3202 (2022)
Hepatocellular carcinoma (HCC) is the most frequent liver cancer with high lethality and low five-year survival rates leading to a substantial worldwide burden for healthcare systems. HCC initiation and progression are favored by different etiologica
Externí odkaz:
https://doaj.org/article/ffdd89af2fa34443824c502c09e96b95
Autor:
Gülow, Marlen Michalski, Magdalena Bauer, Franziska Walz, Deniz Tümen, Philipp Heumann, Petra Stöckert, Manuela Gunckel, Claudia Kunst, Arne Kandulski, Stephan Schmid, Martina Müller, Karsten
Publikováno v:
Biomedicines; Volume 11; Issue 6; Pages: 1666
Despite the recent approval of new therapies, the prognosis for patients with hepatocellular carcinoma (HCC) remains poor. There is a clinical need for new highly effective therapeutic options. Here, we present a combined application of BH3-mimetics
Publikováno v:
50. Jahrestagung der Gesellschaft für Gastroenterologie in Bayern e.V..
Publikováno v:
39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber.
Autor:
Philipp Heumann, Miguel E. Aguado-Barrera, Barbara Avuzzi, David Azria, Erik Briers, Renée Bultijnck, Ananya Choudhury, Dirk De Ruysscher, Marie-Pierre Farcy-Jacquet, Valérie Fonteyne, Antonio Gómez Caamaño, Irmgard Helmbold, Kerstie Johnson, Sarah L. Kerns, Maarten Lambrecht, Zoe Lingard, Tiziana Rancati, Barry S. Rosenstein, Elena Sperk, R. Paul Symonds, Christopher Talbot, Riccardo Valdagni, Ana Vega, Liv Veldeman, Tim Ward, Adam Webb, Catharine M. West, Jenny Chang-Claude, Petra Seibold
Publikováno v:
Radiotherapy and Oncology, 178:109426. Elsevier Ireland Ltd
RADIOTHERAPY AND ONCOLOGY
RADIOTHERAPY AND ONCOLOGY
Introduction: Previous studies showed that healthcare professionals and patients had only moderate to low agreement on their assessment of treatment-related symptoms. We aimed to determine the levels of agreement in a large cohort of prostate cancer
Publikováno v:
Zeitschrift für Gastroenterologie.
Autor:
André Ramm, Konrad Schütze, Torsten Schlüter, Olga Zavaritskaya, Anna Koenen, Antje Steinbach, Rainer Rettig, Rudolf Schubert, Olaf Grisk, Philipp Heumann
Publikováno v:
Journal of Hypertension. 34:692-703
OBJECTIVES Sympathetic denervation enhances agonist-induced vasoconstriction. This effect may involve altered function of signaling mechanisms such as Rho kinase (Rock) and L-type Ca channels downstream from vasoconstrictor receptors. We tested if en